Read More

InMed Pharmaceuticals Provides Update On INM-089 In The Treatment Of Dry Age-Related Macular Degeneration; Small Molecule Drug Acting As A Preferential Signaling Ligand For CB1/CB2

InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration   ● Small molecule drug acting as a preferential signaling ligand for CB1/CB2 ● Delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement in in vivo preclinical disease model

INM

Read More

Why Jaguar Health Stock Is Up Today

Jaguar Health shares are trading higher Tuesday after the company announced it has signed an exclusive 5-year in-license agreement with Venture Life Group. The license agreement is for the U.S. market for Venture Life's FDA-approved prescription product, Gelclair. Gelclair is for the treatment of oral mucositis, also called "chemo mouth." "We are very happy to have executed the in-license agreement for Gelclair - and thus to have initiated Jaguar's commercial footprint in our core focus area of cancer supportive care," said Lisa Conte, Jaguar's president and CEO.

JAGX

Read More

Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.35% to 37,865.71 while the NASDAQ fell 0.13% to 15,865.09. The S&P 500 also fell, dropping, 0.12% to 5,055.53.

BAC

Read More

Nauticus Robotics And 2 Other Stocks Under $3 Insiders Are Buying

The Dow Jones index closed lower by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BLND